EAM Investors, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 132 filers reported holding CTI BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
EAM Investors, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2022$2,739,000
-45.5%
470,576
-44.1%
0.60%
-51.5%
Q2 2022$5,025,000
+6.3%
841,749
-16.8%
1.23%
+39.4%
Q1 2022$4,726,000
+511.4%
1,011,935
+321.4%
0.88%
+592.9%
Q4 2020$773,000–240,108–0.13%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders